These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31201689)

  • 1. Non-alcoholic fatty liver disease and coronary atherosclerosis-does myocardial glucose metabolism provide the missing link?
    Clifford SM; Murphy DJ
    J Nucl Cardiol; 2021 Apr; 28(2):621-623. PubMed ID: 31201689
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.
    Tang K; Lin J; Ji X; Lin T; Sun D; Zheng X; Wang L
    J Nucl Cardiol; 2021 Apr; 28(2):610-620. PubMed ID: 31077075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
    Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
    J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease.
    Pinarbaşi B; Demır K; Oflaz H; Ahishali E; Akyüz F; Elıtok A; Çımen AO; Gölcük E; Güllüoğlu M; İşsever H; Beşişik F; Kaymakoğlu S; Ökten A
    Turk J Gastroenterol; 2012; 23(6):720-6. PubMed ID: 23794311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
    Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
    Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by
    Tang K; Zheng X; Lin J; Zheng M; Lin H; Li T; Wang L
    J Nucl Cardiol; 2020 Oct; 27(5):1679-1688. PubMed ID: 30238301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease is associated with coronary artery disease and subclinical atherosclerosis.
    Aronow WS
    Future Cardiol; 2016 Jul; 12(4):393-6. PubMed ID: 27291253
    [No Abstract]   [Full Text] [Related]  

  • 9. Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation.
    Tan SH; Zhou XL
    Clinics (Sao Paulo); 2023; 78():100301. PubMed ID: 37952443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.
    Gaggini M; Morelli M; Buzzigoli E; DeFronzo RA; Bugianesi E; Gastaldelli A
    Nutrients; 2013 May; 5(5):1544-60. PubMed ID: 23666091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis and Non-Alcoholic Fatty Liver Disease.
    Balta S
    Angiology; 2022 Sep; 73(8):701-711. PubMed ID: 35476909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANALYSIS THE METABOLIC STATUS OF PATIENTS WITH CORONARY ARTERY DISEASE AND NONALCOHOLIC FATTY LIVER DISEASE DEPENDING ON BODY MASS INDEX.
    Maksymets T; Sorochka-Sirko M; Bondarenko O; Karpyshyn N; Bochar O; Bochar V; Sklyarov E
    Wiad Lek; 2023; 76(1):41-45. PubMed ID: 36883488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis.
    Abdallah LR; de Matos RC; E Souza YPDM; Vieira-Soares D; Muller-Machado G; Pollo-Flores P
    Curr Atheroscler Rep; 2020 Feb; 22(1):7. PubMed ID: 32020371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to: liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease.
    Stender S; Tybjaerg-Hansen A
    Eur Heart J; 2018 Sep; 39(36):3399. PubMed ID: 29733360
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation of the relationship between non-alcoholic fatty liver disease and coronary artery disease.
    Topuz M; Dogan A; Celik A; Can C; Ozdogru I; Kemal Eryol N
    Clin Ter; 2014; 165(1):e46-51. PubMed ID: 24589960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of fatty liver by computed tomography coronary artery calcium score.
    Kerut SE; Balart JT; Kerut EK; McMullan MR
    Echocardiography; 2017 Jun; 34(6):937-938. PubMed ID: 28493399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the relationship between non-alcoholic fatty liver disease and CAD using MSCT.
    Efe D; Aygün F
    Arq Bras Cardiol; 2014 Jan; 102(1):10-8. PubMed ID: 24263777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study.
    Lee MK; Park HJ; Jeon WS; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    Cardiovasc Diabetol; 2015 Jul; 14():88. PubMed ID: 26169265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis.
    Hsiao CC; Teng PH; Wu YJ; Shen YW; Mar GY; Wu FZ
    BMC Cardiovasc Disord; 2021 May; 21(1):244. PubMed ID: 34011282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Yip GW; Lo AO; Limquiaco J; Chu WC; Chim AM; Yu CM; Yu J; Chan FK; Sung JJ; Chan HL
    Gut; 2011 Dec; 60(12):1721-7. PubMed ID: 21602530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.